Comparison of 3 investigational assays for the free form of prostate specific antigen

Journal of Urology

Volumn 160, Issue 2, 1998, Pages 420-425

  Nixon, Randy G ^a   Meyer, Grant E ^a   Blase, Amy B ^a   Gold, Mitchell H ^a   Brawer, Michael K ^a  

^a NONE

Author keywords

Biological markers; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

BIOLOGICAL MARKER; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 0032323053     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62913-6     Document Type: Article

References (20)

1. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J., Petros, J. A., and Andriole, G. L.: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Engl. J. Med., 324: 1156, 1991.
2. Brawer, M. K., Chetner, M. P., Beatie, J., Buchner, D. M., Vessella, R. L. and Lange, P. H.: Screening for prostatic carcinoma with prostate specific antigen. J. Urol., 147: 841, 1992.
3. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J.A.M.A., 270: 948, 1993.
4. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. and Redwine, E.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med., 317: 909, 1987.
5. Cooner, W. H., Mosley, B. R., Rutherford, C. L., Jr., Beard, J. H., Pond, H. S., Terry, W. J., Igel, T. C. and Kidd, D. D.: Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J. Urol., 143: 1146, 1990.
6. Brawer, M. K. and Lange, P. H.: PSA in the screening, staging and follow-up of early-stage prostate cancer. A review of recent developments. World J. Urol., 7: 7, 1989.
7. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res., 51: 222, 1991.
8. Luderer, A. A., Chen, Y. T., Soriano, T. F., Kramp, W. J., Carlson, G., Cuny, C., Sharp, T., Smith, W., Petteway, J. and Brawer, M. K.: Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology, 46: 187, 1995.
9. Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., Ratliff, T. L. and Nadler, R. B.: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J.A.M.A., 274: 1214, 1995.
10. Thiel, R. P., Oesterling, J. E., Wojno, K. J., Partin, A. W., Chan, D. W., Carter, H. B., Stamey, T. A., Prestigiacomo, A. R., Brawer, M. K., Petteway, J. C., Carlson, G. and Luderer, A. A.: Multicenter comparison of the diagnostic performance of free prostate-specific antigen. Urology, 48: 45, 1996.
11. Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Patal, A., Flanigan, R. C., Richie, J. P., deKernian, J. B., Walsh, P. C., Scardino, P. T., Lange, P. H., Herschman, J. D., Subong, E. N. P., Petteway, J. C., Parson, R. E., Loveland, K. G., Gasior, G. H. and Southwick, P. C.: A multicenter clinical trial evaluation of free PSA in the determination of prostate cancer from benign disease. J. Urol., part 2, 157: 11, abstract 434, 1997.
12. Vashi, A. R., Wojno, K. J., Henricks, W., England, B. A., Vessella, R. L., Lange, P. H., Wright, G. L., Jr., Schellhammer, P. F., Weigand, R. A., Olson, R. M., Dowell, B. L., Borden, K. K. and Oesterling, J. E.: Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system. Urology, 49: 19, 1997.
13. Littrup, P. J., Kane, R. A., Mettlin, C. J., Murphy, G. P., Lee, F., Toi, A., Badalament, R., Babaian, R. and Investigators of the American Cancer Society National Prostate Cancer Detection Project: Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Cancer, 74: 3146, 1994.
14. Bland, J. M. and Altman, D. G.: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 8476: 307, 1986.
15. Brawer, M. K., Daum, P., Petteway, J. C. and Wener, M. H.: Assay variability in serum prostate-specific antigen determination. Prostate, 27: 1, 1995.
16. Drawer, M. K., Daum, P., Tagle, W. S., Blumenstein, B. A., Lange, P. H., Vassella, R. L. and Wener, M. H.: Variability in serum PSA level owing to different manufacturers assay: results of a prospective study. J. Urol., part 2, 153: 464A, abstract 944, 1995.
17. Brawer, M. K., Bankson, D. D., Haver, V. M. and Petteway, J. C.: Comparison of three commercial PSA assays: results of restandardization of the Ciba Corning method. Prostate, 30: 269, 1997.
18. Stamey, T. A.: Second Stanford Conference on International Standardization of Prostate-Specific Antigen Immunoassays, September 1-2, 1994. Urology, 45: 173, 1995.
19. Chen, Z., Prestigiacomo, A. and Stamey, T. A.: Purification and characterization of prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin: potential reference material for international standardization of PSA immunoassays. Clin. Chem., 41: 1273, 1995.
20. Partin, A. W., Catalona, W. J., Southwick, P. C., Subong, E. N., Gasior, G. H. and Chan, D. W.: Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology, suppl., 48: 55, 1996.